Saudi investments, FDA fastrack and more 👀

Find out what’s moving and why this morning                                                                                                                                                                                                                                                                                                                                                                                                                 Good day, 360 – Here are our top investing ideas today – and just a heads up Jeff Bishop is opening up [Wall Street Bookie to everyone at 2EST.]([Â]( Be the best prepared trader on the Street! CNTG - Up over 90% in pre-market after forming Saudi Arabian JV ACIU - Up over 17% in pre receiving FDA fast track designation for Alzheimer’s drug ASTC - Up over 19% in pre after 13D filing shows BML Investment Partners, L.P increased its stake in the company 📈[Today, June 27, 2PM EST](📈 That’s When Jeff’s Hosting A Rare Bonus Trading Session. Last Minute, I know, But With Markets AT Support… Jeff’s Saying He HAS To Do This! Lucky For You, Your Names On The Invitation List. Three New Trades Await! [BE HERE AT 2PM EST!]( CNTG - Up over 90% in pre-market after forming Saudi Arabian JV Centongene N.V (CNTG) engages in the research and development of products for human genetics. This morning[the company announced]( that it had entered into a strategic collaboration with Lifera, forming a Saudi Arabian joint venture (JV) to increase access to data-driven multiomic testing: “CENTOGENE will receive a $30 million investment in the form of a mandatory convertible loan with a six-month term and a conversion price of $2.20 per share of CENTOGENE’s common stock, as well as significant JV performance-related milestone payments and revenue-based royalties until the year 2033.” The $1.30 level was support in the pre-market and will be an important area to watch. Above it, targets to the upside are $1.40, $1.50 and then the pre-market high at $1.70. Beyond that, $1.83, $2, $2.10 and $2.50 come into play. Below $1.30, there is potential support at $1.20, $1.17, $1, $0.90 and a gap to fill at $0.7824. ACIU - Up over 17% after receiving FDA fast track designation for Alzheimer’s drug AC Immune SA (ACIU), a clinical stage biopharmaceutical company, discovers, designs and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. This morning, ACIU [announced]( that it had secured FDA Fast Track Designation for its anti-amyloid-beta active immunotherapy ACI-24.060 to treat Alzheimer’s disease. The stock was trading 17% higher in pre-market on the news. ACIU found support at the $2.20 level and this will be an important area to watch. Above it, targets to the upside are at $2.40, $2.50 and then the pre-market high of $2.73. Below $2.20, there is potential support at $2.15, $2.10 and then a gap to fill to $1.98. ASTC - Up over 19% in pre-market after 13D filing shows BML Investment Partners, L.P, increased its stake in the company Astrotech (ASTC) operates as a mass spectrometry company worldwide. In the afterhours yesterday, a [13D filing showed]( that BML Investment Partners, L.P., had increased its stake in ASTC to 13% of the company. ASTC was up over 19% this morning on the news. $13 has acted as support so far in the pre-market and will be an important level to watch. Above it, targets to the upside are $14, $15 and then the pre-market high at $15.29. Beyond that, $16.20, $16.50 and $17 come into play. Below $13, there is potential support at $12.50, $12 and then a gap to fill at $11.54. [Economic Calendar]( To Your Success!   Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull  DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [( FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. RagingBull .com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States [[beehiiv logo]Powered by beehiiv](